Electrophoresis testing - FY25 delivery order
Ended Awarded Last action
- Contract number
- W81K0024F0071
- Awardee
-
Sebia, Inc. UEI WKVRJJ6G6VB5
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $446,839
Award facts
- Opportunity
-
- Sources Sought Notice - Electrophoresis Testing Platform & Reagents Pre-Solicitation · W81K0023R0021 · Posted Nov 18, 2022
- Contract value 100% obligated
- $446,838.55 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- 2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $446,839 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $446,838.55 firm fixed-price delivery order to Sebia, Inc. for electrophoresis testing services, specifically for Hydragel 9 IF Dynamic Mask products with a completion deadline of September 30, 2025. The work will be performed at Fort Sam Houston in San Antonio, Texas. This delivery order was issued without a small business set-aside and represents a continuation of Sebia's established role as a critical supplier of advanced laboratory diagnostic equipment and services to federal healthcare agencies.
This award leverages Sebia's existing $4.47 million indefinite delivery contract with the Defense Health Agency through September 30, 2028, which covers electrophoresis testing equipment and reagents at San Antonio Military Medical Center. Sebia, headquartered in Norcross, Georgia, is a global leader in automated electrophoresis technologies and maintains an extensive portfolio of federal supply schedule contracts and indefinite delivery vehicles across the Veterans Health Administration and Department of Defense medical systems. The company specializes in capillary electrophoresis instruments, serum and urine protein analysis, hemoglobin testing, and immunofixation diagnostics that support complex clinical laboratory operations across the federal healthcare system.
Quick answers
Who was awarded contract W81K0024F0071?
W81K0024F0071 was awarded to Sebia, Inc. by Medical Command (Department of the Army) on October 1, 2024.
How much is contract W81K0024F0071 worth?
The government has obligated $446,839 on W81K0024F0071.
Which agency awarded contract W81K0024F0071?
Medical Command (Department of the Army) awarded W81K0024F0071, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0024F0071 an order under another contract?
Yes. W81K0024F0071 is a delivery order under W81K0023D0007, an indefinite delivery contract.
Was contract W81K0024F0071 competed?
The extent of competition for W81K0024F0071 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award